655
Views
0
CrossRef citations to date
0
Altmetric
Biochemistry, Cell and Molecular Biology

Effects of different doses of levosimendan combined with Shenmai injection on immune function and galectin-3 and HSP70 levels in rats with acute heart failure

, , , , &
Pages 1073-1080 | Received 10 Dec 2020, Accepted 04 Nov 2021, Published online: 19 Nov 2021

References

  • Baggen VJM, van den Bosch AE, Eindhoven JA, Menting ME, Witsenburg M, Cuypers J, Boersma E, Roos-Hesselink JW. 2018. Prognostic value of galectin-3 in adults with congenital heart disease. Heart. 104(5):394–400.
  • Cabiati M, Botta L, Caselli C, Del Ry S. 2020. Transcriptional evaluation of relaxin and endothelin-1 axis in heart failure patients: first evidence of its involvement during left ventricular assist device support. Int J Cardiol. 306:109–115.
  • Chen LJ, Zhang RG, Yu DD, Wu G, Dong XR. 2019. Shenqi Fuzheng injection ameliorates radiation-induced brain injury. Curr Med Sci. 39(6):965–971.
  • Chen Q, Huang M, Wu J, Jiang Q, Zheng X. 2020a. Exosomes isolated from the plasma of remote ischemic conditioning rats improved cardiac function and angiogenesis after myocardial infarction through targeting Hsp70. Aging. 12(4):3682–3693.
  • Chen RJ, Rui QL, Wang Q, Tian F, Wu J, Kong XQ. 2020b. Shenfu injection attenuates lipopolysaccharide-induced myocardial inflammation and apoptosis in rats. Chin J Nat Med. 18(3):226–233.
  • Cheng Y, Rong J. 2019. Pro-resolving lipid mediators as therapeutic leads for cardiovascular diseases. Expert Opin Ther Targets. 23(5):423–436.
  • Comín-Colet J, Manito N, Segovia-Cubero J, Delgado J, García Pinilla JM, Almenar L, Crespo-Leiro MG, Sionis A, Blasco T, Pascual-Figal D, et al. 2018. Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial. Eur J Heart Fail. 20(7):1128–1136.
  • Eskandari V, Amirzargar AA, Mahmoudi MJ, Rahnemoon Z, Rahmani F, Sadati S, Rahmati Z, Gorzin F, Hedayat M, Rezaei N. 2018. Gene expression and levels of IL-6 and TNFα in PBMCs correlate with severity and functional class in patients with chronic heart failure. Ir J Med Sci. 187(2):359–368.
  • Fu R, Noguchi H, Kaneko S, Kawamura A, Kang C, Takahashi H, Tamiya N. 2019. How do cardiovascular diseases harm labor force participation? Evidence of nationally representative survey data from Japan, a super-aged society. PLoS One. 14(7):e0219149.
  • Gu T, Wang RH, Wu T, Ke ZH, Yang H, Wang D. 2020. [Therapeutic effect on mild perimenopausal depression treated with acupuncture at the “thirteen ghost points” and kaixin powder]. Zhongguo Zhen Jiu. 40(3):267–271.
  • Gulyaev NI, Akhmetshin IM, Gordienco AV, Yakovlev VV. 2020. Sarcopenia as the reason of hypodiagnostics of chronic kidney disease in patients with chronic heart failure. Adv Gerontol. 33(1):121–126.
  • Hansen MS, Andersen A, Nielsen-Kudsk JE. 2018. Levosimendan in pulmonary hypertension and right heart failure. Pulm Circ. 8(3):2045894018790905.
  • Hong T, Li LX, Han XP, Shi JL, Dan CY, Liu ZY, Wu XB. 2020. Effect of Astragalus membranaceus oral solution on lifespan and learning and memory ability of honey bees. Biomed Res Int. 2020:5745048.
  • Jiang YR, Du JY, Wang DD, Yang X. 2018. miRNA-130a improves cardiac function by down-regulating TNF-α expression in a rat model of heart failure. Eur Rev Med Pharmacol Sci. 22(23):8454–8461.
  • Johnson JL. 2019. Elucidating the contributory role of microRNA to cardiovascular diseases (a review). Vascul Pharmacol. 114:31–48.
  • Levijoki J, Pollesello P, Kaheinen P, Haikala H. 2001. Improved survival with levosimendan after experimental myocardial infarction in rats. Eur J Pharmacol. 419(2–3):243–248.
  • Li F, Zhang D, Lu X, Wang Y, Xiong Z. 2004. Enatiomeric analysis of levosimendan by CE with beta-CD as chiral selector compared with CMPA-HPLC. Biomed Chromatogr. 18(10):866–871.
  • Li L, Yang D, Li J, Niu L, Chen Y, Zhao X, Oduro PK, Wei C, Xu Z, Wang Q, et al. 2020. Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation. BMC Complement Med Ther. 20(1):112.
  • Lino DOC, Freitas IA, Meneses GC, Martins AMC, Daher EF, Rocha JHC, Silva Junior GB. 2019. Interleukin-6 and adhesion molecules VCAM-1 and ICAM-1 as biomarkers of post-acute myocardial infarction heart failure. Braz J Med Biol Res. 52(12):e8658.
  • Mazloumi E, Poorolajal J, Sarrafzadegan N, Roohafza HR, Faradmal J, Karami M. 2019. Avoidable burden of cardiovascular diseases in the eastern Mediterranean region: contribution of selected risk factors for cardiovascular-related deaths. High Blood Press Cardiovasc Prev. 26(3):227–237.
  • Mohamed AS, Hosney M, Bassiony H, Hassanein SS, Soliman AM, Fahmy SR, Gaafar K. 2020. Sodium pentobarbital dosages for exsanguination affect biochemical, molecular and histological measurements in rats. Sci Rep. 10(1):378.
  • Noale M, Limongi F, Maggi S. 2020. Epidemiology of cardiovascular diseases in the elderly. Adv Exp Med Biol. 1216:29–38.
  • Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF. 2020. Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use. Card Fail Rev. 6:e19.
  • Pu X, Chai Y, Guan L, Li W, Gao J, Jiang Z, Li Q, Wu Y, Chen Y. 2020. Astragalus improve aging bone marrow mesenchymal stem cells (BMSCs) vitality and osteogenesis through VD-FGF23-Klotho axis. Int J Clin Exp Pathol. 13(4):721–729.
  • Raczkiewicz D, Bojar I, Wdowiak A, Rzeźnicki A, Krakowiak J. 2019. Stress at intellectual work and cardiovascular diseases in women at non-mobility working age. Ann Agric Environ Med. 26(3):456–461.
  • Segiet OA, Piecuch A, Mielanczyk L, Michalski M, Nowalany-Kozielska E. 2019. Role of interleukins in heart failure with reduced ejection fraction. Anatol J Cardiol. 22(6):287–299.
  • Shen Q, Chen W, Liu J, Liang Q. 2019. Galectin-3 aggravates pulmonary arterial hypertension via immunomodulation in congenital heart disease. Life Sci. 232:116546.
  • Shi H, Wang L, Fang ZH, Ni YQ, Shen AL, Liu PP, Wang X, Huang JL. 2019. [Experimental study on effect and mechanism of Danzhi Jiangtang Capsules on diabetic myocardial injury]. Zhongguo Zhong Yao Za Zhi. 44(23):5159–5165.
  • Song N, Ma J, Meng XW, Liu H, Wang H, Song SY, Chen QC, Liu HY, Zhang J, Peng K. 2020. Heat shock protein 70 protects the heart from ischemia/reperfusion injury through inhibition of p38 MAPK signaling. Oxid Med Cell Longev. 2020:3908641.
  • Tulay P, Temel SG, Ergoren MC. 2019. Investigation of KCNQ1 polymorphisms as biomarkers for cardiovascular diseases in the Turkish Cypriots for establishing preventative medical measures. Int J Biol Macromol. 124:537–540.
  • Wang A, Cui C, Fan Y, Zi J, Zhang J, Wang G, Wang F, Wang J, Tan Q. 2019a. Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial. Crit Care. 23(1):428.
  • Wang C, Yao D, Zhang P, Xie X, Wang B, Liu J, Zhang Z. 2019b. Clinical efficacy and safety of Shenqi Fuzheng injection for the treatment of chronic heart failure: protocol for a meta-analysis and systematic review. Medicine (Baltimore). 98(52):e18556.
  • Xu T, Ding W, Ji X, Ao X, Liu Y, Yu W, Wang J. 2019. Oxidative stress in cell death and cardiovascular diseases. Oxid Med Cell Longev. 2019:9030563.
  • Yang F, Zhao LN, Sun Y, Chen Z. 2019. Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application. J Int Med Res. 47(5):1817–1828.
  • Yang L, Zhang C, Chen J, Zhang S, Pan G, Xin Y, Lin L, You Z. 2020. Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway. Pharm Biol. 58(1):276–285.
  • You JS, Huang HF, Chang YL, Lee YS. 2006. Sheng-mai-san reduces adriamycin-induced cardiomyopathy in rats. Am J Chin Med. 34(2):295–305.
  • Zhang MJ, Gu Y, Wang H, Zhu PF, Liu XY, Wu J. 2016. Valsartan attenuates cardiac and renal hypertrophy in rats with experimental cardiorenal syndrome possibly through down-regulating galectin-3 signaling. Eur Rev Med Pharmacol Sci. 20(2):345–354.